Review
doi: 10.3109/09513599409023632.
The poor-responder patient in an in vitro fertilization-embryo transfer (IVF-ET) program
Affiliations
- PMID: 7709768
- DOI: 10.3109/09513599409023632
Item in Clipboard
Review
The poor-responder patient in an in vitro fertilization-embryo transfer (IVF-ET) program
Gynecol Endocrinol.
1994 Dec.
Free article
Abstract
The purpose of this article is to review the methods and evaluate the 'avenues' that are open to patients and physicians in their search for improvement of in vitro fertilization-embryo transfer (IVF-ET) treatment results. The option of egg donation, although very important and viable in the treatment of poor responders, is not described here.
Similar articles
-
In vitro fertilization and embryo transfer in uncontrolled diabetes mellitus.J Assist Reprod Genet. 1995 Jul;12(6):392-3. doi: 10.1007/BF02215732. J Assist Reprod Genet. 1995. PMID: 8589561 No abstract available.
-
[Study on clinical effect on infertility women with polycystic ovary syndrome treated by in vitro maturation and in vitro fertilization-embryo transfer].Zhonghua Fu Chan Ke Za Zhi. 2012 Apr;47(4):250-4. Zhonghua Fu Chan Ke Za Zhi. 2012. PMID: 22781109 Chinese.
-
Dual suppression with oral contraceptives and gonadotrophin releasing-hormone agonists improves in-vitro fertilization outcome in high responder patients.Hum Reprod. 1997 Nov;12(11):2359-65. doi: 10.1093/humrep/12.11.2359. Hum Reprod. 1997. PMID: 9436663
-
Guidelines for the number of embryos to transfer following in vitro fertilization No. 182, September 2006.Int J Gynaecol Obstet. 2008 Aug;102(2):203-16. doi: 10.1016/j.ijgo.2008.01.007. Int J Gynaecol Obstet. 2008. PMID: 18773532 Review.
-
[Treatment of infertility by in vitro fertilization (IVF-ET)].Pol Tyg Lek. 1991 Dec 26-30;46(50-52):1007-10. Pol Tyg Lek. 1991. PMID: 1669181 Review. Polish.
Cited by
-
Predicting IVF outcome in poor ovarian responders.BMC Womens Health. 2022 Sep 30;22(1):395. doi: 10.1186/s12905-022-01964-y. BMC Womens Health. 2022. PMID: 36180882 Free PMC article.
-
Ovarian Follicular Growth through Intermittent Vaginal Gonadotropin Administration in Diminished Ovarian Reserve Women.Pharmaceutics. 2022 Apr 15;14(4):869. doi: 10.3390/pharmaceutics14040869. Pharmaceutics. 2022. PMID: 35456706 Free PMC article.
-
Ovarian Stimulation in Patient-oriented Strategies Encompassing Individualised Oocyte Number-4 Category; Antagonist versus Short-agonist Protocols.J Hum Reprod Sci. 2023 Jul-Sep;16(3):212-217. doi: 10.4103/jhrs.jhrs_72_23. Epub 2023 Sep 29. J Hum Reprod Sci. 2023. PMID: 38045497 Free PMC article.
-
Stop GnRH-Agonist Combined With Multiple-Dose GnRH-Antagonist Protocol for Patients With "Genuine" Poor Response Undergoing Controlled Ovarian Hyperstimulation for IVF.Front Endocrinol (Lausanne). 2020 May 22;11:182. doi: 10.3389/fendo.2020.00182. eCollection 2020. Front Endocrinol (Lausanne). 2020. PMID: 32528403 Free PMC article.
-
A simplified universal approach to COH protocol for IVF: ultrashort flare GnRH-agonist/GnRH-antagonist protocol with tailored mode and timing of final follicular maturation.J Ovarian Res. 2015 Nov 4;8:69. doi: 10.1186/s13048-015-0198-3. J Ovarian Res. 2015. PMID: 26536862 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
